Peripheral blood stem cell transplantation for the treatment of 11 cases with acute leukemia and malignant solid tumors
- VernacularTitle:外周血干细胞移植治疗11例急性白血病和恶性实体瘤
- Author:
Jie CUI
;
Zhanu GU
;
Juyong WANG
- Publication Type:Journal Article
- Keywords:
acute leukemia;
malignant solid tumors;
peripheral blood stem cell transplantation
- From:
China Oncology
2001;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
50?10~(9)/L. Of the patients, 3 died of liver function exhaustion or disease relapse 1-12 months after transplantation , 2 are still alive with disease for 3-5 months , but others are still alive and disease-free for 3-64 months. Conclusions:PBSCT is a safe therapeutic option that can significantly improve in acute leukemia and malignant solid tumors.
